NASDAQ:BDSX
Biodesix Inc Stock News
$1.58
+0.0150 (+0.96%)
At Close: May 17, 2024
Here's Why Biodesix, Inc. (BDSX) Looks Ripe for Bottom Fishing
11:18am, Tuesday, 15'th Mar 2022
Biodesix, Inc. (BDSX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q4 2021 Results - Earnings Call Transcript
01:58pm, Monday, 14'th Mar 2022
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q4 2021 Results - Earnings Call Transcript
Biodesix, Inc. (BDSX) Reports Q4 Loss, Lags Revenue Estimates
08:17am, Monday, 14'th Mar 2022
Biodesix, Inc. (BDSX) delivered earnings and revenue surprises of 2% and 1.45%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Biodesix, Inc. (BDSX) to Report a Decline in Earnings: What to Look Out for
04:31pm, Monday, 07'th Mar 2022
Biodesix, Inc. (BDSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biodesix to Present at Cowen's 42nd Annual Healthcare Conference
06:00am, Tuesday, 01'st Mar 2022
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton,
Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
06:00am, Wednesday, 09'th Feb 2022
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton,
Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates
01:55pm, Monday, 15'th Nov 2021
Biodesix, Inc. (BDSX) delivered earnings and revenue surprises of 0.00% and 8.85%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q3 2021 Results - Earnings Call Transcript
11:37am, Monday, 15'th Nov 2021
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q3 2021 Results - Earnings Call Transcript
Biodesix to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
06:00am, Thursday, 11'th Nov 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton,
Biodesix, Inc. (BDSX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:06pm, Monday, 08'th Nov 2021
Biodesix, Inc. (BDSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biodesix to Report Third Quarter 2021 Financial Results on November 15, 2021
06:00am, Monday, 01'st Nov 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will r
Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting
06:00am, Wednesday, 13'th Oct 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced that multiple data presentations will occur
Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer
09:20am, Thursday, 16'th Sep 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that two abstr
Biodesix to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference
06:00am, Thursday, 02'nd Sep 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton,
Biodesix DeSoto Laboratory Receives both ISO 13485:2016 Certification and Accreditation from the College of American Pathologists
06:00am, Wednesday, 25'th Aug 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX). Today Biodesix announced that the Accreditation Committee of the College of American Pathologists (CAP) and Bri
